Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 1/20 | 0.46 |
| ▸ | DGKA | P23743 | 1/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.46 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.46 |
| ▸ | ALDH2 | P05091 | 2/20 | 0.44 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | CYSLTR2 | Q9NS75 | 2/20 | 0.44 |
| ▸ | CYSLTR1 | Q9Y271 | 2/20 | 0.44 |
| ▸ | LTA4H | P09960 | 4/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19912241 | 0.91 | DGKA (0.50) | DGKACNR2PLA2G2AHDAC3HDAC4 | |
| SCHEMBL1284955 | 0.85 | LTA4H (0.52) | BRD4FFAR1PDK2CYSLTR2CYSLTR1 | |
| SCHEMBL1285180 | 0.85 | LTA4H (0.52) | BRD4FFAR1PDK2CYSLTR2CYSLTR1 | |
| SCHEMBL1285034 | 0.83 | LTA4H (0.53) | BRD4PDK2CYSLTR2CYSLTR1LTA4H | |
| SCHEMBL2828409 | 0.79 | PLA2G2A (0.47) | BRD4TDP1PLA2G2A | |
| SCHEMBL18205386 | 0.79 | CYSLTR2 (0.47) | BRD4DGKAFFAR1PDK2ALDH2 | |
| SCHEMBL987722 | 0.79 | CYSLTR2 (0.56) | BRD4PDK2CYSLTR2CYSLTR1ALDH1A1 | |
| SCHEMBL16607364 | 0.78 | CYP1A2 (0.60) | BRD4PDK2CYP3A4CYP1A2CYP2C19 | |
| SCHEMBL1194316 | 0.78 | PDK2 (0.51) | BRD4DGKAFFAR1PDK2ALDH2 | |
| SCHEMBL1171721 | 0.78 | LTA4H (0.61) | CYSLTR2CYSLTR1LTA4HTSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11639937-B2 | Fluorescent methods and materials for directed biomarker signal amplification | SIRIGEN II LIMITED (GB) | 2023-05-02 | — | — | US | disclosed |
| US-11639937-B2 | Fluorescent methods and materials for directed biomarker signal amplification | SIRIGEN II LIMITED (GB) | 2023-05-02 | — | — | US | disclosed |
| US-20170115298-A1 | FLUORESCENT METHODS AND MATERIALS FOR DIRECTED BIOMARKER SIGNAL AMPLIFICATION | SIRIGEN II LIMITED (GB) | 2017-04-27 | — | — | US | disclosed |
| US-20170115298-A1 | FLUORESCENT METHODS AND MATERIALS FOR DIRECTED BIOMARKER SIGNAL AMPLIFICATION | SIRIGEN II LIMITED (GB) | 2017-04-27 | — | — | US | disclosed |
| US-20160266132-A1 | FLUORESCENT METHODS AND MATERIALS FOR DIRECTED BIOMARKER SIGNAL AMPLIFICATION | SIRIGEN II LIMITED (GB) | 2016-09-15 | — | — | US | disclosed |
| US-20160266132-A1 | FLUORESCENT METHODS AND MATERIALS FOR DIRECTED BIOMARKER SIGNAL AMPLIFICATION | SIRIGEN II LIMITED (GB) | 2016-09-15 | — | — | US | disclosed |
| US-9383353-B2 | Fluorescent methods and materials for directed biomarker signal amplification | SIRIGEN INC. (US) | 2016-07-05 | — | — | US | disclosed |
| US-9383353-B2 | Fluorescent methods and materials for directed biomarker signal amplification | SIRIGEN INC. (US) | 2016-07-05 | — | — | US | disclosed |
| EP-2164988-B1 | FLUORESCENT METHODS AND MATERIALS FOR DIRECTED BIOMARKER SIGNAL AMPLIFICATION | SIRIGEN INC (US) | 2016-02-17 | — | — | EP | disclosed |
| US-20150309016-A1 | Fluorescent Methods and Materials for Directed Biomarker Signal Amplification | SIRIGEN INC. | 2015-10-29 | — | — | US | disclosed |
| US-8354239-B2 | Fluorescent methods and materials for directed biomarker signal amplification | SIRIGEN, INC. (US) | 2013-01-15 | — | — | US | disclosed |
| US-8158444-B2 | Fluorescent methods and materials for directed biomarker signal amplification | SIRIGEN, INC. (GB) | 2012-04-17 | — | — | US | disclosed |
| US-8158444-B2 | Fluorescent methods and materials for directed biomarker signal amplification | SIRIGEN, INC. (GB) | 2012-04-17 | — | — | US | disclosed |
| US-20120029155-A1 | Fluorescent Methods and Materials for Directed Biomarker Signal Amplification | SIRIGEN INC. (US) | 2012-02-02 | — | — | US | disclosed |
| US-20120028828-A1 | Fluorescent Methods and Materials for Directed Biomarker Signal Amplification | SIRIGEN INC. (US) | 2012-02-02 | — | — | US | disclosed |
| US-20120028828-A1 | Fluorescent Methods and Materials for Directed Biomarker Signal Amplification | SIRIGEN INC. (US) | 2012-02-02 | — | — | US | disclosed |
| US-20120029155-A1 | Fluorescent Methods and Materials for Directed Biomarker Signal Amplification | SIRIGEN INC. (US) | 2012-02-02 | — | — | US | disclosed |
| US-20080293164-A1 | Fluorescent Methods and Materials for Directed Biomarker Signal Amplification | SIRIGEN INC. | 2008-11-27 | — | — | US | disclosed |
| US-20080293164-A1 | Fluorescent Methods and Materials for Directed Biomarker Signal Amplification | SIRIGEN INC. | 2008-11-27 | — | — | US | disclosed |
| WO-2008100344-A2 | FLUORESCENT METHODS AND MATERIALS FOR DIRECTED BIOMARKER SIGNAL AMPLIFICATION | SIRIGEN INC. (US) | 2008-08-21 | — | — | WO | disclosed |